Agilon Health (AGL) Competitors $1.11 +0.05 (+4.72%) Closing price 08/15/2025 03:59 PM EasternExtended Trading$1.11 0.00 (0.00%) As of 08/15/2025 07:53 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock AGL vs. VRDN, AVAH, AHCO, TDOC, GRAL, PNTG, FLGT, CDNA, FTRE, and CSTLShould you be buying Agilon Health stock or one of its competitors? The main competitors of Agilon Health include Viridian Therapeutics (VRDN), Aveanna Healthcare (AVAH), AdaptHealth (AHCO), Teladoc Health (TDOC), GRAIL (GRAL), The Pennant Group (PNTG), Fulgent Genetics (FLGT), CareDx (CDNA), Fortrea (FTRE), and Castle Biosciences (CSTL). These companies are all part of the "healthcare" industry. Agilon Health vs. Its Competitors Viridian Therapeutics Aveanna Healthcare AdaptHealth Teladoc Health GRAIL The Pennant Group Fulgent Genetics CareDx Fortrea Castle Biosciences Viridian Therapeutics (NASDAQ:VRDN) and Agilon Health (NYSE:AGL) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, institutional ownership, dividends, analyst recommendations, media sentiment, profitability, risk and earnings. Do analysts prefer VRDN or AGL? Viridian Therapeutics presently has a consensus target price of $37.00, indicating a potential upside of 99.57%. Agilon Health has a consensus target price of $3.58, indicating a potential upside of 222.39%. Given Agilon Health's higher possible upside, analysts clearly believe Agilon Health is more favorable than Viridian Therapeutics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Viridian Therapeutics 0 Sell rating(s) 1 Hold rating(s) 8 Buy rating(s) 0 Strong Buy rating(s) 2.89Agilon Health 2 Sell rating(s) 11 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.17 Which has more risk & volatility, VRDN or AGL? Viridian Therapeutics has a beta of 0.42, meaning that its share price is 58% less volatile than the S&P 500. Comparatively, Agilon Health has a beta of 0.14, meaning that its share price is 86% less volatile than the S&P 500. Does the media refer more to VRDN or AGL? In the previous week, Viridian Therapeutics had 6 more articles in the media than Agilon Health. MarketBeat recorded 20 mentions for Viridian Therapeutics and 14 mentions for Agilon Health. Viridian Therapeutics' average media sentiment score of 0.67 beat Agilon Health's score of 0.07 indicating that Viridian Therapeutics is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Viridian Therapeutics 4 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Agilon Health 1 Very Positive mention(s) 2 Positive mention(s) 7 Neutral mention(s) 3 Negative mention(s) 0 Very Negative mention(s) Neutral Which has preferable earnings and valuation, VRDN or AGL? Agilon Health has higher revenue and earnings than Viridian Therapeutics. Viridian Therapeutics is trading at a lower price-to-earnings ratio than Agilon Health, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioViridian Therapeutics$300K5,046.59-$269.95M-$3.83-4.84Agilon Health$6.06B0.08-$260.15M-$0.77-1.44 Is VRDN or AGL more profitable? Agilon Health has a net margin of -5.35% compared to Viridian Therapeutics' net margin of -112,806.88%. Agilon Health's return on equity of -66.76% beat Viridian Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Viridian Therapeutics-112,806.88% -78.95% -49.91% Agilon Health -5.35%-66.76%-17.47% SummaryAgilon Health beats Viridian Therapeutics on 7 of the 13 factors compared between the two stocks. Get Agilon Health News Delivered to You Automatically Sign up to receive the latest news and ratings for AGL and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding AGL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart AGL vs. The Competition Export to ExcelMetricAgilon HealthMedical Services IndustryMedical SectorNYSE ExchangeMarket Cap$460.01M$7.66B$5.72B$20.91BDividend YieldN/A2.71%3.91%3.62%P/E RatioN/A76.5731.1428.08Price / Sales0.0827.25416.9674.32Price / CashN/A24.0236.7823.73Price / Book0.9717.309.085.26Net Income-$260.15M$243.10M$3.26B$994.11M7 Day Performance27.31%3.01%7.39%1.80%1 Month Performance-49.20%0.80%4.22%0.81%1 Year Performance-77.11%18.72%30.30%13.44% Agilon Health Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)AGLAgilon Health2.6085 of 5 stars$1.11+4.7%$3.58+222.4%-77.1%$460.01M$6.06B0.001,076News CoverageAnalyst ForecastVRDNViridian Therapeutics1.7319 of 5 stars$16.89+2.9%$37.00+119.1%+19.7%$1.38B$305K-4.4150AVAHAveanna Healthcare1.8163 of 5 stars$6.83+11.2%$6.10-10.7%+42.5%$1.33B$2.09B85.3833,500News CoverageAnalyst ForecastHigh Trading VolumeAHCOAdaptHealth3.9975 of 5 stars$9.33+1.5%$13.40+43.6%-9.4%$1.26B$3.26B17.2810,500TDOCTeladoc Health3.2725 of 5 stars$6.79-2.5%$9.76+43.9%+5.5%$1.20B$2.57B-5.705,500News CoveragePositive NewsAnalyst RevisionGRALGRAIL1.077 of 5 stars$32.69-0.4%$31.50-3.6%+93.6%$1.18B$130.71M-0.541,360News CoverageEarnings ReportPNTGThe Pennant Group3.9012 of 5 stars$26.15+0.6%$33.80+29.3%-20.4%$903.74M$695.24M33.537,000Analyst ForecastHigh Trading VolumeFLGTFulgent Genetics3.6804 of 5 stars$20.61+1.2%$25.33+22.9%-9.5%$630.85M$303.22M-12.421,313Positive NewsCDNACareDx4.0973 of 5 stars$11.77-1.7%$27.67+135.1%-64.1%$626.52M$333.79M11.54740FTREFortrea3.9684 of 5 stars$6.39-2.9%$14.00+119.1%-63.9%$580.21M$2.70B-0.5615,500Positive NewsCSTLCastle Biosciences2.7717 of 5 stars$19.16-1.0%$37.00+93.1%-25.6%$555.83M$332.07M-54.74540 Related Companies and Tools Related Companies Viridian Therapeutics Alternatives Aveanna Healthcare Alternatives AdaptHealth Alternatives Teladoc Health Alternatives GRAIL Alternatives The Pennant Group Alternatives Fulgent Genetics Alternatives CareDx Alternatives Fortrea Alternatives Castle Biosciences Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:AGL) was last updated on 8/17/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Agilon Health, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Agilon Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access